Characteristics of Mel Ibr Melanoma Line Subclone after Treatment with Chicken Embryo Extract


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We continue analysis of the phenotype of human melanoma cell Mel Ibr subclone obtained previously by treatment of the parental cell line by chicken embryo extract. The present study is focused on detection of markers of epithelial-mesenchymal transition that determine enhanced metastatic and invasive potential of malignant tumors of various locations. Analysis of the expression of E-cadherin and vimentin genes in the subclone and parental cells detected activation of epithelial-mesenchymal transition in the subclone. Immunological markers CD90, CD271, and CD95 were present in the parental population, but were not detected on the subclone cells. In contrast to the parental line, cells of the analyzed subclone retain viability in serum-free medium and formed vessel-like structures characteristic of vasculogenic mimicry.

Sobre autores

N. Suraeva

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Autor responsável pela correspondência
Email: nsuraeva@yandex.ru
Rússia, Moscow

L. Morozova

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: nsuraeva@yandex.ru
Rússia, Moscow

O. Ryabaya

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: nsuraeva@yandex.ru
Rússia, Moscow

Yu. Khochenkova

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: nsuraeva@yandex.ru
Rússia, Moscow

A. Samoilov

All-Russian Research Institute of Preservation Technology

Email: nsuraeva@yandex.ru
Rússia, Moscow Region

O. Burova

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: nsuraeva@yandex.ru
Rússia, Moscow

N. Golubtsova

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: nsuraeva@yandex.ru
Rússia, Moscow

A. Barmashov

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: nsuraeva@yandex.ru
Rússia, Moscow

M. Baryshnikova

N. N. Blokhin Russian Cancer Research Center, Ministry of Health of the Russian Federation

Email: nsuraeva@yandex.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, 2017

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies